Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment

Aging Cell

Volumn 15, Issue 2, 2016, Pages 208-216

  Lopes, Sofia ^a,b   Lopes, André ^a,b   Pinto, Vítor ^a,b   Guimarães, Marco R ^a,b   Sardinha, Vanessa Morais ^a,b   Duarte Silva, Sara ^a,b   Pinheiro, Sara ^a,b   Pizarro, João ^a,b   Oliveira, João Filipe ^a,b   Sousa, Nuno ^a,b   Leite Almeida, Hugo ^a,b   Sotiropoulos, Ioannis ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

Knockout; Motor deficits; Myelination; Nerve conduction; Peripheral nerve; Tau

Indexed keywords

TAU PROTEIN;

ADULT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EFFERENT NERVE; GAIT; LOCOMOTION; MALE; MORPHOLOGY; MOTOR DYSFUNCTION; MOTOR FUNCTION TEST; MOTOR PERFORMANCE; MOUSE; MYELINATED NERVE; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SCIATIC NERVE; SCIATIC NEUROPATHY; ULTRASTRUCTURE; WILD TYPE; ALZHEIMER DISEASE; ANIMAL; DEFICIENCY; DISEASE MODEL; KNOCKOUT MOUSE; METABOLISM; NERVE CONDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURAL CONDUCTION; SCIATIC NERVE; TAU PROTEINS;

EID: 84960087157     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12391     Document Type: Article

References (45)

1. Bohl J, Ulbricht D, Steinmetz H (1997) Neurofibrillary tangles in peripheral autonomic ganglion cells. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics (Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM, eds). Chichester: John Wiley & Sons, pp. 281-287.
2. Boyne LJ, Tessler A, Murray M, Fischer I (1995) Distribution of Big tau in the central nervous system of the adult and developing rat. J. Comp. Neurol. 358, 279-293.
3. Buchman AS, Bennett DA (2011) Loss of motor function in preclinical Alzheimer's disease. Expert Rev. Neurother. 11, 665-676.
4. Ceballos D, Cuadras J, Verdu E, Navarro X (1999) Morphometric and ultrastructural changes with ageing in mouse peripheral nerve. J. Anat. 195(Pt 4), 563-576.
5. Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP (2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J. Cell Sci. 114, 1179-1187.
6. Decker L, Desmarquet-Trin-Dinh C, Taillebourg E, Ghislain J, Vallat JM, Charnay P (2006) Peripheral myelin maintenance is a dynamic process requiring constant Krox20 expression. J. Neurosci. 26, 9771-9779.
7. Duker AP, Espay AJ, Wszolek ZK, Rademakers R, Dickson DW, Kelley BJ (2012) Atypical motor and behavioral presentations of Alzheimer disease: a case-based approach. Neurologist 18, 266-272.
8. Frappier TF, Georgieff IS, Brown K, Shelanski ML (1994) Tau regulation of microtubule-microtubule spacing and bundling. J. Neurochem. 63, 2288-2294.
9. Frost B, Gotz J, Feany MB (2015) Connecting the dots between tau dysfunction and neurodegeneration. Trends Cell Biol. 25, 46-53.
10. Georgieff IS, Liem RK, Mellado W, Nunez J, Shelanski ML (1991) High molecular weight tau: preferential localization in the peripheral nervous system. J. Cell Sci. 100(Pt 1), 55-60.
11. Gotz J, Ittner A, Ittner LM (2012) Tau-targeted treatment strategies in Alzheimer's disease. Br. J. Pharmacol. 165, 1246-1259.
12. Gotz J, Xia D, Leinenga G, Chew YL, Nicholas H (2013) What renders TAU toxic. Front Neurol. 4, 72.
13. Gumucio A, Lannfelt L, Nilsson LN (2013) Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging. BMC Neurosci. 14, 148.
14. Holzer M, Holzapfel HP, Krohn K, Gertz HJ, Arendt T (1999) Alterations in content and phosphorylation state of cytoskeletal proteins in the sciatic nerve during ageing and in Alzheimer's disease. J. Neural. Transm. 106, 743-755.
15. Ikegami S, Harada A, Hirokawa N (2000) Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci. Lett. 279, 129-132.
16. Ittner LM, Gotz J (2011) Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65-72.
17. Ke YD, Suchowerska AK, van der Hoven J, De Silva DM, Wu CW, van Eersel J, Ittner A, Ittner LM (2012) Lessons from tau-deficient mice. Int. J. Alzheimers Dis. 2012, 873270.
18. Kirkpatrick LL, Brady ST (1994) Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells. J. Neurosci. 14, 7440-7450.
19. Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J (2002) Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J. Neurosci. 22, 698-707.
20. Kramer-Albers EM, White R (2011) From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell. Mol. Life Sci. 68, 2003-2012.
21. Ksiezak-Reding H, Binder LI, Yen SH (1988) Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1. J. Biol. Chem. 263, 7948-7953.
22. Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BX, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, McLean CA, Cappai R, Duce JA, Bush AI (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 18, 291-295.
23. Lei P, Ayton S, Moon S, Zhang Q, Volitakis I, Finkelstein DI, Bush AI (2014) Motor and cognitive deficits in aged tau knockout mice in two background strains. Mol. Neurodegener. 9, 29.
24. LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc. Natl Acad. Sci. USA 92, 10369-10373.
25. Ma QL, Zuo X, Yang F, Ubeda OJ, Gant DJ, Alaverdyan M, Kiosea NC, Nazari S, Chen PP, Nothias F, Chan P, Teng E, Frautschy SA, Cole GM (2014) Loss of MAP function leads to hippocampal synapse loss and deficits in the morris water maze with aging. J. Neurosci. 34, 7124-7136.
26. Melcangi RC, Magnaghi V, Martini L (2000) Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones. Prog. Neurobiol. 60, 291-308.
27. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700-703.
28. Morris M, Koyama A, Masliah E, Mucke L (2011) Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease. PLoS ONE 6, e29257.
29. Morris M, Hamto P, Adame A, Devidze N, Masliah E, Mucke L (2013) Age-appropriate cognition and subtle dopamine-independent motor deficits in aged tau knockout mice. Neurobiol. Aging 34, 1523-1529.
30. Muller R, Heinrich M, Heck S, Blohm D, Richter-Landsberg C (1997) Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes. Cell Tissue Res. 288, 239-249.
31. Murphy P, Topilko P, Schneider-Maunoury S, Seitanidou T, Baron-Van Evercooren A, Charnay P (1996) The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 122, 2847-2857.
32. Nothias F, Boyne L, Murray M, Tessler A, Fischer I (1995) The expression and distribution of tau proteins and messenger RNA in rat dorsal root ganglion neurons during development and regeneration. Neuroscience 66, 707-719.
33. Petit B, Giraudet F, Bechon C, Bardin L, Avan P, Boespflug-Tanguy O, Begou M (2014) Mice with a deletion of the major central myelin protein exhibit hypersensitivity to noxious thermal stimuli: involvement of central sensitization. Neurobiol. Dis. 65, 55-68.
34. Pinto V, Szucs P, Derkach VA, Safronov BV (2008) Monosynaptic convergence of C- and Adelta-afferent fibres from different segmental dorsal roots on to single substantia gelatinosa neurones in the rat spinal cord. J. Physiol. 586, 4165-4177.
35. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
36. Sato-Yoshitake R, Shiomura Y, Miyasaka H, Hirokawa N (1989) Microtubule-associated protein 1B: molecular structure, localization, and phosphorylation-dependent expression in developing neurons. Neuron 3, 229-238.
37. Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y (2004) Motor signs during the course of Alzheimer disease. Neurology 63, 975-982.
38. Silva-Fernandes A, Duarte-Silva S, Neves-Carvalho A, Amorim M, Soares-Cunha C, Oliveira P, Thirstrup K, Teixeira-Castro A, Maciel P (2014) Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease. Neurotherapeutics 11, 433-449.
39. Song J, Goetz BD, Kirvell SL, Butt AM, Duncan ID (2001) Selective myelin defects in the anterior medullary velum of the taiep mutant rat. Glia 33, 1-11.
40. Ubhi KK, Shaibah H, Newman TA, Shepherd D, Mudher A (2007) A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies. Invert. Neurosci. 7, 165-171.
41. Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, Cui B, Mucke L (2010) Tau reduction prevents Abeta-induced defects in axonal transport. Science 330, 198.
42. Wilson RS, Bennett DA, Gilley DW, Beckett LA, Schneider JA, Evans DA (2000) Progression of parkinsonian signs in Alzheimer's disease. Neurology 54, 1284-1289.
43. Yuan A, Kumar A, Peterhoff C, Duff K, Nixon RA (2008) Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice. J. Neurosci. 28, 1682-1687.
44. Zhang B, Maiti A, Shively S, Lakhani F, McDonald-Jones G, Bruce J, Lee EB, Xie SX, Joyce S, Li C, Toleikis PM, Lee VM, Trojanowski JQ (2005) Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl Acad. Sci. USA 102, 227-231.
45. Zhukareva V, Sundarraj S, Mann D, Sjogren M, Blenow K, Clark CM, McKeel DW, Goate A, Lippa CF, Vonsattel JP, Growdon JH, Trojanowski JQ, Lee VM (2003) Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol. 105, 469-476.